
Halena Leah Marcelin, PHARMD, MS, BCPS
Advertisement
Articles by Halena Leah Marcelin, PHARMD, MS, BCPS


The 340B program launched in 1992 to “stretch scarce federal resources” in order for participating entities to increase accessibility to care (eg, medications, clinical services, etc) for patients.

The 340B Drug Pricing Program began in 1992 with the intent of permitting covered entities “to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.”

Since its induction in 1992, the 340B Drug Pricing Program has been responsible for helping eligible covered entities stretch scarce federal resources and increase services to patients of the covered entity.
Advertisement
Latest Updated Articles
340B Compliance: Tips to Maintaining a Successful ProgramNovember 22nd 2016
340B Audit: Building a Self-Audit ProgramMay 16th 2017
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D
2
ADA 2026: Why Some T2D Patients Don't Respond to GLP-1 RAs—And What Pharmacists Should Screen For
3
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
4
New Research Suggests Bempedoic Acid Outperforms Ezetimibe for Heart Health in Patients with Type 2 Diabetes
5
